KIT and gastrointestinal stromal tumor: To investigate the impact of CDK7 on c-KIT expression in GIST cells and the synergistic effect of THZ1 and imatinib, GIST-T1 and GIST-882 cells, which both harbour c-KIT gene mutations and are sensitive to imatinib, were used in our research.